$746 Million is the total value of HARBOURVEST PARTNERS LLC's 44 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 123.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
W | New | Wayfair, Inc. | $334,304,000 | – | 1,062,126 | +100.0% | 44.84% | – |
SWI | Solarwinds Corp. | $129,740,000 | +16.7% | 7,439,200 | 0.0% | 17.40% | -60.0% | |
SNOW | New | Snowflake Computing, Inc. | $72,964,000 | – | 318,233 | +100.0% | 9.79% | – |
EVLO | Evelo Biosciences, Inc. | $32,780,000 | -11.5% | 3,063,505 | 0.0% | 4.40% | -69.6% | |
RUBY | Rubius Therapeutics, Inc. | $26,152,000 | +249.2% | 986,878 | 0.0% | 3.51% | +19.8% | |
SGTX | Sigilon Therapeutics, Inc. | $16,556,000 | -53.5% | 740,740 | 0.0% | 2.22% | -84.0% | |
NARI | New | Inari Medical | $15,780,000 | – | 147,475 | +100.0% | 2.12% | – |
KLDO | Kaleido BioSciences, Inc. | $14,854,000 | -11.0% | 1,833,832 | 0.0% | 1.99% | -69.5% | |
RBLX | New | Roblox Corporation | $14,105,000 | – | 217,569 | +100.0% | 1.89% | – |
AXLA | Axcella Health, Inc. | $13,366,000 | -8.3% | 2,807,981 | 0.0% | 1.79% | -68.5% | |
RLAY | New | Relay Therapeutics, Inc. | $10,247,000 | – | 296,402 | +100.0% | 1.37% | – |
LC | LendingClub Corp. | $8,482,000 | +56.4% | 513,440 | 0.0% | 1.14% | -46.3% | |
IBRX | New | ImmunityBio, Inc. | $8,238,000 | – | 347,009 | +100.0% | 1.10% | – |
EB | New | Eventbrite, Inc. | $8,212,000 | – | 370,564 | +100.0% | 1.10% | – |
DDOG | New | Datadog, Inc. | $7,764,000 | – | 93,162 | +100.0% | 1.04% | – |
TWLO | New | Twilio, Inc. | $4,966,000 | – | 14,572 | +100.0% | 0.67% | – |
DASH | New | DoorDash, Inc. | $3,921,000 | – | 29,903 | +100.0% | 0.53% | – |
LOV | Sell | Spark Networks SEsponsored adr | $3,733,000 | +39.6% | 501,026 | -0.3% | 0.50% | -52.1% |
CRWD | New | CrowdStrike Holdings, Inc. | $2,496,000 | – | 13,676 | +100.0% | 0.34% | – |
ZUO | Zuora, Inc. | $2,426,000 | +6.3% | 163,894 | 0.0% | 0.32% | -63.6% | |
U | New | Unity Software | $2,197,000 | – | 21,899 | +100.0% | 0.30% | – |
AFRM | New | Affirm, Inc. | $1,984,000 | – | 28,053 | +100.0% | 0.27% | – |
YEXT | Yext, Inc. | $1,667,000 | -7.9% | 115,147 | 0.0% | 0.22% | -68.3% | |
MCRB | Sell | Seres Therapeutics, Inc. | $1,016,000 | -50.6% | 49,363 | -41.2% | 0.14% | -83.1% |
PACB | New | Pacific Biosciences of California, Inc. | $782,000 | – | 23,484 | +100.0% | 0.10% | – |
DCT | New | Duck Creek Technologies, Inc. | $655,000 | – | 14,508 | +100.0% | 0.09% | – |
NET | New | CloudFlare, Inc. | $652,000 | – | 9,278 | +100.0% | 0.09% | – |
OYST | New | Oyster Point Pharma, Inc. | $625,000 | – | 34,185 | +100.0% | 0.08% | – |
CTMX | Cytomx Therapeutics, Inc. | $612,000 | +17.9% | 79,193 | 0.0% | 0.08% | -59.6% | |
CSLT | Castlight Health, Inc. | $527,000 | +16.1% | 349,070 | 0.0% | 0.07% | -59.9% | |
SPT | New | Sprout Social, Inc. | $502,000 | – | 8,692 | +100.0% | 0.07% | – |
New | Marinus Pharmaceuticals, Inc. | $479,000 | – | 30,962 | +100.0% | 0.06% | – | |
FROG | New | Jfrog | $477,000 | – | 10,756 | +100.0% | 0.06% | – |
TRVN | Trevena, Inc. | $419,000 | -16.2% | 233,850 | 0.0% | 0.06% | -71.3% | |
YMTX | Yumanity | $399,000 | +6.4% | 22,030 | 0.0% | 0.05% | -63.3% | |
RPTX | New | Repare Therapeutics, Inc. | $377,000 | – | 12,276 | +100.0% | 0.05% | – |
RAPT | New | Rapt Therapeutics, Inc. | $274,000 | – | 12,351 | +100.0% | 0.04% | – |
PMVP | New | PMV Pharmaceuticals | $253,000 | – | 7,692 | +100.0% | 0.03% | – |
EPZM | Epizyme, Inc. | $215,000 | -19.8% | 24,686 | 0.0% | 0.03% | -72.4% | |
JNCE | New | Jounce Therapeutics, Inc. | $205,000 | – | 19,927 | +100.0% | 0.03% | – |
NXTC | NextCure, Inc. | $101,000 | -7.3% | 10,044 | 0.0% | 0.01% | -67.4% | |
METC | Ramaco Resources, Inc. | $63,000 | +46.5% | 14,951 | 0.0% | 0.01% | -52.9% | |
AM | New | Antero Midstream GP | $30,000 | – | 3,316 | +100.0% | 0.00% | – |
HNRG | Hallador Energy Resources, Inc. | $27,000 | +28.6% | 14,270 | 0.0% | 0.00% | -50.0% | |
Exit | Rapt Therapeutics, Inc. | $0 | – | -12,351 | -100.0% | -0.10% | – | |
XGN | Exit | Exagen, Inc. | $0 | – | -25,982 | -100.0% | -0.13% | – |
AR | Exit | Antero Resources LLC | $0 | – | -131,895 | -100.0% | -0.28% | – |
PGNY | Exit | Progyny, Inc. | $0 | – | -29,743 | -100.0% | -0.49% | – |
ADVM | Exit | Adverum Biotechnologies, Inc. | $0 | – | -134,154 | -100.0% | -0.57% | – |
WORK | Exit | Slack Technologies, Inc. | $0 | – | -61,037 | -100.0% | -1.01% | – |
TDOC | Exit | TelaDoc Health, Inc. | $0 | – | -50,943 | -100.0% | -3.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
Trevena, Inc. | 25 | Q4 2021 | 1.2% |
Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
Zuora, Inc. | 21 | Q3 2023 | 3.4% |
Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
LendingClub Corp. | 18 | Q3 2019 | 11.9% |
Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
40-APP | 2024-04-24 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR/A | 2022-05-26 |
13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.